You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Attention Score in Context
| Title |
Beyond clinical trials: real-world impact of immunotherapy on NSCLC in Jordan
|
|---|---|
| Published in |
Frontiers in oncology, April 2024
|
| DOI | 10.3389/fonc.2024.1369126 |
| Pubmed ID | |
| Authors |
Taher Abu Hejleh, Karim AlSawalha, Sufian Abdel Hafiz, Tamer Al-Batsh, Roaa Abu Hejleh, Sameer Yaser, Husam Abu Jazar, Jamal Khader, Anoud Alnsour, Issa Mohamad, Riad Abdel Jalil, Ahmad Abu-Shanab, Azza Gharaibeh, Mohammad Abu Shattal, Akram Alibraheem, Hussam Haddad, Naser Mahmoud, Shadi Obeidat, Mohammed J. Al-Jaghbeer, Muhammad Furqan, Alessio Cortellini, Vamsidhar Velcheti, Kamal Al-rabi |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 April 2024.
All research outputs
#23,277,548
of 25,942,066 outputs
Outputs from Frontiers in oncology
#16,296
of 22,843 outputs
Outputs of similar age
#172,969
of 216,252 outputs
Outputs of similar age from Frontiers in oncology
#177
of 220 outputs
Altmetric has tracked 25,942,066 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,843 research outputs from this source. They receive a mean Attention Score of 3.1. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 216,252 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 220 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.